Anyone with concerns about Pediatrix’s conduct or its accounting, internal accounting controls or auditing matters may report it directly to the chair of the board (or lead independent director), non-management directors or the audit committee. Such communications may be confidential or anonymous and submitted via email, in writing or reported by phone. All concerns will be forwarded to the appropriate directors and Pediatrix’s general counsel or chief compliance officer for review. All outstanding concerns will be reported to the directors quarterly or sooner, depending on the concern that has been raised. Non-management directors, the chair of the board (or lead independent director) or the audit committee may retain outside advisors or counsel for any matter presented to them. Pediatrix’s code-of-conduct prohibits any associate from retaliating or taking adverse actions against anyone who, in good faith, raises or reports a concern.